Adenosine Receptor Agonists Modulate Visceral Hyperalgesia in the Rat.
- Author:
Chong Il SOHN
1
;
Hyo Jin PARK
;
G F GEBHART
Author Information
1. Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea. chongil.sohn@samsung.com
- Publication Type:Original Article
- Keywords:
Adenosine;
Visceral;
Hyperalgesia
- MeSH:
Adenosine;
Adenosine-5'-(N-ethylcarboxamide);
Animals;
Hindlimb;
Hyperalgesia;
Injections, Subcutaneous;
Nociception;
Purinergic P1 Receptor Agonists;
Rats;
Receptors, Purinergic P1;
Zymosan
- From:Gut and Liver
2008;2(1):39-46
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Adenosine is an endogenous modulator of nociception. Its role in visceral nociception, particularly in visceral hyperalgesia, has not been studied. The aim of this study was to determine the effects of adenosine receptor agonists in a model of visceral hyperalgesia. METHODS: The visceromotor response (VMR) in rats to colorectal distension (CRD; 80 mmHg, 20 seconds) was quantified by electromyographic recordings from the abdominal musculature. Three hours after the intracolonic administration of zymosan (25 mg/mL, 1 mL), VMRs to CRD were measured before and after either subcutaneous or intrathecal administration of an adenosine receptor agonist. RESULTS: Subcutaneous injection of 5'-N-ethylcarboxyamidoadenosine (NECA; an A1 and A2 receptor agonist), R(-)-N6-(2-phenylisopropyl)-adenosine (R-PIA; a selective A1 receptor agonist), or CGS-21680 hydrochloride (a selective A2a receptor agonist) dose-dependently (10-100 mg/kg) attenuated the VMR to CRD, although hindlimb weakness occurred at the higher doses tested. Intrathecal administration of NECA or R-PIA dose-dependently (0.1-1.0 microgram/kg) decreased the VMR, whereas CGS-21680 hydrochloride was ineffective over the same concentration range. Higher intrathecal doses of the A1/A2 receptor agonist NECA produced motor weakness. CONCLUSIONS: Adenosine receptor agonists are antihyperalgesic, but also produce motor weakness at high doses. However, activation of the spinal A1 receptor significantly attenuates the VMR to CRD without producing motor weakness.
